EA202191907A1 - APPLICATION OF VIBEGRON FOR TREATMENT OF HYPERACTIVE BLADDER - Google Patents

APPLICATION OF VIBEGRON FOR TREATMENT OF HYPERACTIVE BLADDER

Info

Publication number
EA202191907A1
EA202191907A1 EA202191907A EA202191907A EA202191907A1 EA 202191907 A1 EA202191907 A1 EA 202191907A1 EA 202191907 A EA202191907 A EA 202191907A EA 202191907 A EA202191907 A EA 202191907A EA 202191907 A1 EA202191907 A1 EA 202191907A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
vibegron
application
hyperactive bladder
bladder
Prior art date
Application number
EA202191907A
Other languages
Russian (ru)
Inventor
мл. Пол Н. Мадд
Original Assignee
Уровант Сайенсиз Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Уровант Сайенсиз Гмбх filed Critical Уровант Сайенсиз Гмбх
Priority claimed from PCT/IB2020/052484 external-priority patent/WO2020188505A1/en
Publication of EA202191907A1 publication Critical patent/EA202191907A1/en

Links

Abstract

Изобретение относится к способу лечения гиперактивного мочевого пузыря, включающему пероральное введение нуждающемуся в этом субъекту количества 75 мг вибегрона в сутки.The invention relates to a method for the treatment of overactive bladder, comprising the oral administration to a subject in need of this amount of 75 mg of Vibegron per day.

EA202191907A 2019-09-23 2020-03-18 APPLICATION OF VIBEGRON FOR TREATMENT OF HYPERACTIVE BLADDER EA202191907A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962904429P 2019-09-23 2019-09-23
PCT/IB2020/052484 WO2020188505A1 (en) 2019-03-18 2020-03-18 Use of vibegron to treat overactive bladder

Publications (1)

Publication Number Publication Date
EA202191907A1 true EA202191907A1 (en) 2021-11-26

Family

ID=78768141

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191907A EA202191907A1 (en) 2019-09-23 2020-03-18 APPLICATION OF VIBEGRON FOR TREATMENT OF HYPERACTIVE BLADDER

Country Status (1)

Country Link
EA (1) EA202191907A1 (en)

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
MX2020007092A (en) Methods of using ehmt2 inhibitors in treating or preventing blood disorders.
MX2022006865A (en) Substituted tetrahydrofurans as modulators of sodium channels.
EA202092490A1 (en) METHYL-MODIFYING ENZYMES MODULATORS, COMPOSITIONS AND THEIR APPLICATION
EA201691454A1 (en) COMPOSITIONS OF PRIDOPIDININE MODIFIED SHIPPING
CL2019000485A1 (en) Use of pridopidine for the treatment of functional decline.
EP3970712A3 (en) Solid oral dosage forms of 2r,6r-hydroxynorketamine or derivatives thereof
MX2020010300A (en) Mono-(acid) salts of 6-aminoisoquinolines and uses thereof.
EA201990424A1 (en) SPIRALACTAM MODULERS OF NMDA RECEPTOR AND THEIR APPLICATION
EA201990428A1 (en) SPIRALACTAM MODULERS OF NMDA RECEPTOR AND THEIR APPLICATION
EA202193015A1 (en) CDK INHIBITORS
MX2022015629A (en) Use of vibegron to treat overactive bladder.
MX2023000187A (en) Dosing of vibegron for treatment of overactive bladder.
MX2022000143A (en) Novel methods.
PH12019550154A1 (en) Azetidine derivative
PH12021551223A1 (en) Decarboxylase inhibitors for treating parkinson`s disease
EA201892098A1 (en) COMPOUND POSSESSING INHIBITING MUTANT IDH ACTIVITY, METHOD FOR PRODUCING AND APPLICATION
MX2018014129A (en) Pharmaceutical composition comprising eteplirsen.
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
EA202191907A1 (en) APPLICATION OF VIBEGRON FOR TREATMENT OF HYPERACTIVE BLADDER
EA202193276A1 (en) METHODS FOR THE TREATMENT OF CHOLANGIOCARCINOMA
TW201713630A (en) Substituted quinazoline compounds and methods of use thereof
EA202193211A1 (en) TREATMENT OF SYNUCLEOPATHIES
MX2021001394A (en) Method for improving anticancer agent efficacy.
EA202090416A1 (en) METHODS FOR TREATING GASTROPARESIS SYMPTOMS USING A VELUSETRAGA